Cilt: 20 Sayı: 2

1985 yılında İstanbul’da doğan Doç. Dr. Yavuz Onur Danacıoğlu, Bülent Ecevit Üniversitesi Tıp Fakültesi bölümünden 2010 yılında mezun olarak tıp eğitimini tamamlamıştır. Üroloji ihtisasını 2018 yılında Medeniyet Üniversitesi Göztepe Eğitim ve Araştırma Hastanesi’nde başarıyla tamamlayarak Üroloji Uzmanı unvanını almıştır.

İhtisas süresi içinde 2014 yılında Amerika Birleşik Devletleri Cornell Üniversitesinde Androloji deneyimlerini artırmak için bir süre görev almıştır. Ulusal ve merkezi yapılan sınavı başarıyla geçerek Türk Üroloji Yeterlilik Sertifikası almaya hak kazanmış. Ardından uluslararası olarak gerçekleştirilen Avrupa Üroloji Board yeterlilik sınavını başarıyla geçerek FEBU ünvanı almaya hak kazanmıştır.

Mecburi hizmetini Ağrı Devlet Hastanesi’nde Üroloji Uzmanı olarak yapmış, kariyerine Bakırköy Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi’nde devam etmiş ve burada 2022 yılında Doçent unvanını almıştır. Aynı hastanede, Sağlık Bilimleri Üniversitesi Bakırköy Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi Üroloji Kliniği Eğitim Görevlisi olarak çalışmaktadır. Uzmanlık sonrasında ki yıllarda çalışmalarını özellikle Androloji, Endo-üroloji, Üro-onkoloji, Nöroüroloji ve Rekonstrüktif üroloji üzerine yoğunlaştırmıştır. Mesleki yaşantısı; ürolojinin tüm alanları ile yoğun ilgilenerek ve bu alanlardaki her türden pek çok zorlu cerrahi müdahalelere katılarak geçmiştir.

Ulusal ve Uluslararası hakemli dergilerde 140'dan fazla makale ve 9 kitap bölümü yayımlayan Danacıoğlu’nun çalışmaları 418 kez atıf almıştır. Bilimsel başarıları, en iyi video ve en iyi poster ödülleri ile uluslararası kongrelerde takdir edilmiştir. Üroloji alanında Türkiye’nin önde gelen bilimsel dergilerinden biri olan The New Journal of Urology Dergisi’nde Editörlük görevini sürdürmektedir.

Doç. Dr. Yavuz Onur Danacıoğlu, mesleki kariyerinde edindiği bilgi ve tecrübelerle hastalarına en üst düzeyde sağlık hizmeti sunmayı amaçlamaktadır. Yenilikçi tedavi yöntemleri konusundaki uzmanlığı ile tanınan Doç. Dr. Danacıoğlu, hastalarına modern ve etkili çözümler sunmaktadır.

2- Yayınlar

BİLİMSEL KURULUŞLARA ÜYELİKLER

TÜRK ÜROLOJİ DERNEĞİ

TÜRK ENDOÜROLOJİ DERNEĞİ

TÜRK ANDROLOJİ DERNEĞİ

AVRASYA ÜROONKOLOJİ DERNEĞİ

ÖDÜLLER ve SERTİFİKALAR

· Araştırma planlaması ve İstatistiksel Değerlendirme, 2015

· Türk Üroloji Yeterlilik Belgesi, 2016

· Deney Hayvanları Kullanım Sertifikası, 2016

· Avrupa Üroloji Yeterlilik Belgesi, 2017

· Da Vinci System Training First Assistant, 2018

· 5. İstanbul Ürolitiyazis Günleri En iyi Poster Ödülü - 2017

· 33. Avrupa Üroloji Kongresi En iyi Poster Ödülü – 2018

· 9. Avrasya Üroonkoloji Kongresi En İyi İkinci Sözlü Sunum Ödülü – 2019

· 39. SIU kongresi En iyi Poster Ödülü – 2019

· 28. Ulusal Üroloji Kongresi En İyi Üçüncü Bildiri Ödülü – 2019

· AcademicGeriatricsAssociation E-Congress En iyi Bildiri Ödülü- 2020

· Çocuk Üroloji Kongresi En iyi Sözlü Bildiri Üçüncülük Ödülü - 2021

GÖREV ALINAN KURS EĞİTMENLİKLERİ

1.KURS EĞİTMENİ

1 E 1 YERİNDE CANLI PERİNEOSKOPİK ÜRETROPLASTİ KURSU, BAKIRKÖY DR SADİ KONUK EĞİTİM VE ARAŞTIRMA HASTANESİ, KURS, 07.02.2020 -07.02.2020 (ULUSAL)

2. KURS EĞİTMENİ

ENDOÜROLOJİ DERNEĞİ 1 E 1 YERİNDE CANLI SUPİN PCNL (ECIRS) KURSU BAKIRKÖY DR SADİ KONUK EĞİTİM VE ARAŞTIRMA HASTANESİ, 14.02.2020 -14.02.2020 (ULUSAL)

3. KURS EĞİTMENİ

TÜRK ÜROLOJİ AKADEMİSİ 1 E 1 YERİNDE CANLI ÜRETROPLASTİ KURSU, BAKIRKÖY DR SADİ KONUK EĞİTİM VE ARAŞTIRMA HASTANESİ, 27.12.2019 -27.12.2019 (ULUSAL)

4. KURS EĞİTMENİ

1 E 1 YERİNDE CANLI PERİNEOSKOPİK ÜRETROPLASTİ KURSU, BAKIRKÖY DR SADİ KONUK EĞİTİM VE ARAŞTIRMA HASTANESİ, 12.12.2019 -13.12.2019 (ULUSAL)

5. KURS EĞİTMENİ

1 E 1 YERİNDE CANLI PERİNEAL RADİKAL PROSTATEKTOMİ KURSU, BAKIRKÖY DR SADİ KONUK EĞİTİM VE ARAŞTIRMA HASTANESİ, 22.11.2019 -22.11.2019 (ULUSAL)

6. KURS EĞİTMENİ

ENDOÜROLOJİ DERNEĞİ 1 E 1 YERİNDE CANLI ECIRS KURSU, BAKIRKÖY DR SADİ KONUK EĞİTİM VE ARAŞTIRMA HASTANESİ, 24.05.2019 -24.05.2019 (ULUSAL)

BİLİMSEL DERGİ ve KİTAPLARDAKİ EDİTÖRLÜK

· The New Journal of Urology, Editörlük, 2023 – Halen

· Androloji Bülteni, Yardımcı Editörlük, 2025 – Halen

· Avrupa Üroloji CepKılavuzu,Türk Üroloji Derneği Yayınları, Çeviri editörlüğü, 2024

· International Journal of Clinical Urology, Danışma Kurulu, 2022 – Halen

TIPTA UZMANLIK TEZİ:

İnterstisyel sistit hayvan modelinde intravezikal hyalüronik asit, kondroitin sülfat ve hyalüronik asit-kondroitin sülfat kombinasyon tedavilerinin karşılaştırılması

ULUSLARARASI HAKEMLİ DERGİLERDE YAYIMLANAN MAKALELER

1- The cost analysis of flexible ureteroscopic lithotripsy in 302 cases. Gurbuz C, Atış G, Arikan O, Efilioglu O, Yıldırım A, Danacıoglu O, Caskurlu T. Urolit; 2014 42: 155-158

2- Comparison of combined antioxidants and thymoquinone in the prevention of testis ischemia - reperfusion injury. Erol B, Sari U, Amasyali AS, Ozkanli S, Sogut S, Hanci V, Efiloglu O, Danacıoglu YO, Engin P, Yencilek F, Atis G, Yildirim A, Alkoc OA, Caskurlu T. Andorology; 2017 5:119-124

3- Bladder Cancer and Genetic Polymorphisms: A Review.Erol B, Ulus I, Danacıoglu YO, Caskurlu T.European Medical Journal Urology 2015 3: 20-25

4- Prevelance of antibiotic resistance in fecal flora before transrectal ultrasound-guided prostate biopsy and the clinical impact of targeted antibiotic prophylaxis. Arikan O, Yildirim A, Atis G, Berrin T, Gurbuz C, Erol B, Danacioglu Y.O, Culpan M, Vahapoglu H, Caskurlu H, Caskurlu T. Arch Esp Urol 2017 70(10):858-858.

5- Can intervals in extracorporeal shock wave lithotripsy sessions affect success in the treatment of upper ureteral stones? Turan T, Efiloglu O, Danacioglu Y.O, Sendogan F, Culpan M, Gunaydın B, Atıs R.G, Caskurlu T, Yildirim A. Videosurgery and Other Miniinvasive Techniques/Wideochirurgia i inne techniki małoinwazyjne. 2018. doi:10.5114/wiitm.2018.75873.

6- The Fate of Residual Fragments After Retrograde Intrarenal Surgery in Long-Term Follow-up. Atis, G., Pelit, E. S., Culpan, M., Gunaydin, B., Turan, T., Danacioglu, Y. O.,Yildirim A, Caskurlu, T. UrolJ doi:10.22037/uj.v0i0.4124

7- Reasons for early readmission after percutaneous nephrolithotomy and retrograde intrarenal surgery. Keskin S.K, Danacioglu Y.O, Turan T., Atis R.G., Canakci C, Caskurlu T, Erol A, Yildirim A. Videosurgery and Other Miniinvasive Techniques doi:10.5114/wiitm.2018.77705

8- Laparoscopy versus robotic assisted pyeloplasty in children: preliminary results of a pilot prospective randomized controlled trial.Sılay M.S, Danacioglu Y.O, Ozel K, Karaman M.İ, Caskurlu T. World Journal of Urology doi: 10.1007/s00345-019-02910-8

9- Re:Laparoscopic transposition of lower-pole crossing vessels: Long-termfollow-upof33patientsatpuberty.SilayM.S,DanaciogluY.O,Caskurlu T.Journal ofpediatricurology12.6(2016): 1

10- The effects of intradetrusor BoNT-A injections on vesicoureteral reflux in children with myelodysplasia. “Toprak T., Danacioglu Y.O., Verit A. International Neurourology J 23.4 (2019) doi: 10.5213/inj.1938100.050

11- Does duration of stenting increase the risk of clinical infection?.Toprak T,,Sahin Aytac, Kutluhan M, Akgul K, Danacioglu Y.O. et al. Archivio ItalianodiUrologiaeAndrologia91.4 (2019):237-240 doi: 10.4081/aiua.2019.4.237

12- Evaluation of factors affecting sexualdysfunction in female patients with diabetes mellitus.Yenice M.G,Danacioglu Y.O. et al. Archives of endocrinology and metabolism 64 (2020):319-325doi:10.20945/2359-3997000000238

13- A nationwide survey on the impact of COVID‐19 pandemic on minimalinvasive surgery in urology practice. Danacioglu Y.O, Soytas M., Polat S.,, Ozdemir O., Arikan O., Yenice M.G, Atis R.G, TasciA.İ International Journal of Clinical Practice (2021): e14309 doi:10.1111/ijcp.14309

14- Effect of focal and diffuse hypervascularization as cystoscopic findings on predicting intravesical therapy response in patients with bladder pain syndrome. Erol B., Danacioglu Y.O. et al. Turkish J of Urol. 47.4 (2021) doi: 10.5152/tju.2021.21093

15- Thepresenceofchronicinflammationin positiveprostatebiopsy isassociatedwithupgradinginradicalprostatectomy."Guner E,DanaciogluY.O,etal. Archivio Italiano di Urologia e Andrologia 93.3 (2021): 280-284 doi:10.4081/aiua.2021.3.280

16- Perioperative myocardial damage and theincidence of type 2 myocardial infarction in patients with intermediate andhigh cardiovascular risk. Keskinler M.V., Köstek O., Erok B., Telci Ö.,DanaciogluY.O., OğuzA.AnatolianJournalof Cardiology25.2(2021):89 doi:10.14744/AnatolJCardiol.2020.45752

17- Female Urethroplasty with dorsal onlay labia minora graft: Technical details and initial results. Simsek A., Danacioglu Y.O. et al. Female Pelvic Medicine & Reconstructive Surgery 27.9 (2021): 560-563 doi:10.1097/SPV.00000000000976

18- Current advances in neuromodulation techniques in urology practices: A review of literature.” Bulent E., Danacioglu Y.O., Kenneth M. Peters. Turkish J of Urol 47.5 (2021): 375-385 doi: 10.5152/tud.2021.21152

19- Comparisonoftwodifferentgraftsforthesurgicaltreatmentofpeyronie’sdisease." Danacıoğlu, Yavuz Onur, Colakoglu Y., Yenice M.G., Keser F., Simsek A., Erol B. Andrologia 53.3 (2021): e13987.doi:10.1111/and.13987

20- Perineoscopic vesicourethral reconstruction: A novel surgical technique for anastomotic stricture following radical prostatectomy. Simsek A., Danacioglu Y.O. et al. Turkish J of Urol 47.1 (2021) doi: 10.5152/tud.2020.20372

21- Management of post-circumcision necrosis of the penis: themedicolegal aspect. Tasci A.İ, Danacioglu Y.O et al. Pediatric surgeryinternational 36.4 (2020): 523-528.

22- The efficiency of prostate-specific antigen density measurement using threedifferent methods on the prediction of biochemical recurrence." DanaciogluY.O, Keser F., Efiloglu O., Culpan M., Polat S., Atıs R.G., Yıldırım A. The Aging Male 24.1 (2021): 15-23.

23- Relationship between the types of urinary incontinence, handgrip strength, and pelvic floor muscle strength in adult women. Soytas R.B, Soytas M., Danacioglu Y.O. et al. Neurourology and Urodynamics 40 (6) (2021): 1532 doi: 10.1000/nau.24699

24- The effects of shock wave lithotripsy and retrograde intrarenal surgery onrenal function."Turan T., Danacioglu Y.O et al. Minimally Invasive Therapy&Allied Technologies(2020): 1-6

25- Testicular torsion in the medicolegal perspective: Why is the diagnosismissing?.TasciA.İ,DanaciogluY.Oetal. TurkishJournalofTraumaandEmergencySurgery 27.2(2021): 207-213

26- Comparison of Intravesical Hyaluronic Acid, Chondroitin Sulfate, and Combination of Hyaluronic Acid-Chondroitin Sulfate Therapies in Animal Model of Interstitial Cystitis.Danacioglu Y.O, Erol B., Ozkanlı S., Yıldırım A., Atıs R.G., Silay M.S., Caskurlu T. Int Neurourol J 25.1 (2021) 42. Doi: 10.5213/inj.1938176.088

27- External validation of the TO HO. score and derivation of the modified TOHO. score for predicting stone-free status after flexible ureteroscopy inureteral and renal stones." Polat S., Danacioglu Y.O. , Soytas M., Yarimoglu S., Koras O., Fakir A.E., Seker K.G., Degirmenci T. Int J Clin Pract (2021):e14653. Doi: 10.1111/ijcp.14653

28- Factorspredictingdurationandsuccessofsemirigidureteroscopy forureteralstones in different localizations." Guner E., Danacioglu Y.O et al. ArchivosEspanolesdeUrologia 74.3 (2021): 335-342

29- Factors predicting the successof intradetrusor onabotulinum toxin-A treatment in children with neurogenic bladders due to myelomeningocele: The outcomes of a large cohort. Danacioglu Y.O, Keser F., Ersoz C., Polat S., Avci A.E., Kalkan S., Silay M.S. Journal of Pediatric Urology (2021), 17 (4) P520.E1-520.E7 Doi:10.1016/j.jpurol.2021.02.020

30- Thepresenceofchronicinflammationin positiveprostatebiopsy isassociatedwithupgradinginradicalprostatectomy."GunerE.,DanaciogluY.O.etal. Archivio ItalianodiUrologiaeAndrologia 93.3(2021):280-284. Doi: 10.4081/aiua.2021.3.280

31- Relationship of MRI-measured pelvimetric dimensions and surgical positions with anaesthesia parameters in robotic perineal prostatectomy. Yenice MG, Danacıoğlu Y.O., Akkaş F, Emir N.S., Şimşek A, Tuğcu V, Tasci A.İ. Arch Esp Urol. 2022 Jan;75(1):69-76. English, Spanish. PMID: 35173071.

32- COVID-19 and Urology: A bibliometric analysis of the literature” Soytas M.,Danacioglu Y.O. et al. International Journal of Clinical Practice Doi:10.1111/ijcp.14965

33- A novel model using computed tomography parameters to predict shock wave lithotripsy success in ureteral stones at different locations. Akkaş F, Culha MG, Ayten A, Danacıoğlu YO, Yildiz Ö, İnci E, Guner E, Şahin S. Actas Urol Esp 2022 Mar; 46:114-121. Doi: 10.1016/j.acuroe.2021.01.011.

34- Supine Percutaneous Nephrolithotomy in a Patient with Solitary Lung: A Case Report and Literature Review. Danacıoğlu YO, Arıkan Y, Akkaş F, Şam E, Özlü DN, Emir NS, Atar FA. Prague Med Rep. 2021;122:294-299. doi: 10.14712/23362936.2021.27. P.

35- Congenital megalourethra and posterior urethral valve in a patient with Down syndrome. Turk J Urol. 2019 Dec; 45:S181-S184. Danacıoğlu Y.O., Karaman M.I., Çaşkurlu T, Sılay M.S.Doi: 10.5152/tud.2018.70852. Epub 2018 Aug 28. PMID: 33120010

36- The optimal settings of holmium YAG laser in treatment of pediatric urolithiasis. Ersoz C., İlktac A., Dogan B., Kalkan S., Danacioglu Y.O., Sılay M.S. Lasers in Medical Science. 37.1 (2022): 317-321

37- Global Practice Patterns in the Evaluation of Non-Obstructive Azoospermia: Results of a World-Wide Survey and Expert Recommendations. Shah R., Danacioglu Y.O et al.World J Mens Health. 2024 Oct;42(4):727-748. Doi: 10.5534/wjmh.230333.

38- Global Andrology Forum. Global Practice Patterns and Variations in the Medical and Surgical Management of Non-Obstructive Azoospermia: Results of a World-Wide Survey, Guidelines and Expert Recommendations. World J Mens Health. Rambhalta A., Danacioglu Y.O. et al, 2024 Apr 4. Doi: 10.5534/wjmh.230339.

39- Analyzing learning curve for supine percutaneous nephrolithotomy in urology resident training programme: comparative analysis. Urolithiasis.Arıkan Y, Danacioğlu Y.O., Özlü D.N., Koraş Ö, Emir B, Keskin M.Z. 2024 9;1:129. Doi: 10.1007/s00240-024-0162

40- The prevalence and topographic distribution of penile calcification in a large cohort: a retrospective cross-sectional study. Int J Impot Res. Baran C., Danacioglu Y.O. et al., 2024 Sep;36(6):576-580. Doi: 10.1038/s41443-023-00758-6.

41- Controversy and Consensus on Indications for Sperm DNA Fragmentation Testing in Male Infertility: A Global Survey, Current Guidelines, and Expert Recommendations. World J Mens Health. Agarwal A., Danacioglu Y.O. et al., 2023 Jul;41(3):575-602. Doi: 10.5534/wjmh.220282.

42- Adaptation of the professionalism mini-evaluation exercise instrument into Turkish: a validity and reliability study. BMC Med Educ. Tasci A.İ., Akdeniz E., Gulpinar M.A., Danacioglu Y.O., Sari E.E., Yasar L., Karandere F., Ferahman S. 2023 Sep 26;23(1):698. Doi: 10.1186/s12909-023-04675-6.

43- The Predictive Factors of Renal Loss After Iatrogenic Ureteral Avulsion in the Medicolegal Perspective. Sisli Etfal Hastan Tip Bul. Tasci A.İ., Danacioglu Y.O., Akkas F., Polat S.,Arikan Y., Guner E., Atar F.A., Buyuk Y. 2023 Mar 21;57:92-98. Doi: 10.14744/SEMB.2022.92603.

44- A Critical Analysis of the Magnetic Resonance Imaging Lesion Diameter Threshold for Adverse Pathology Features. Prague Med Rep. Danacioglu Y.O., Turkay R., Yildiz O., Polat S., Arikan Y., Polat H., Yenice M.G., Baytekin H.F., İnci E., Tasci A.İ. 2023;124:40-51. Doi: 10.14712/23362936.2023.4

45- The Relationship Between Lymphocyte Subtypes with Clinicopathological Features and Prognosis of Prostate Cancer in Patients Undergoing Radical Prostatectomy. Urol Res Pract. Sendogan F., Danacioglu Y.O. et al. 2023 Jul;49:253-258. Doi: 10.5152/tud.2023.22220.

46- External validation of the current scoring systems and derivation of a novel scoring system to predict stone free rates after retrograde intrarenal surgery in patients with cumulative stone diameter of 2-4 cm. Actas Urol Esp. Polat S., Danacioglu Y.O., Yarimoglu Y., Soytas M., Erdogan A., Teke K., Degirmenci T., Tasci A.İ. 2023 May;47:211-220. Doi: 10.1016/j.acuroe.2022.08.015.

47- The role of penile elastography in the evaluation of erectile dysfunction in patients with chronic obstructive pulmonary disease. Cent European J Urol. Yenice M.G., Danacioglu Y.O. Turkay R., Tastan C.P., Artan E., Sam E., Simsek A., Tasci A.İ. 2022;75:96-101. Doi: 10.5173/ceju.2022.0238.

48- Assistant port is unnecessary for robotic-assisted laparoscopic pyeloplasty in children: a comparative cohort study. Pediatr Surg Int. Danacioglu Y.O., Keser F., Polat S. Gunaydın B., Comez Y.I., Silay M.S. 2022 389:1327-34. Doi: 10.1007/s00383-022-05158-3.

ULUSAL HAKEMLİ DERGİLERDE YAYIMLANAN MAKALELER

1- Benign Lesions Detected in Patients Undergoing Nephrectomy for Renal Mass: Single Center Experiences. Güner, E., Danacıoğlu, Y.O., Arıkan, Y., Ekşi, M., Şam, E., Hüseynov, J., Taşçı, A.İ..J Recons Urol, 2019, 9, 73-78. Doi: 10.5336/urology.2019-72133

2- The Current Approaches of Urologist in Treatment of Benign ProstateHyperplasia in Turkey." Sendogan F., Danacioglu Y.O et al. New J Urol 14, 105-113

3- Current Diagnosis, Treatment and Follow-up Procedures of ParatesticularMasses”. Yenice M.G., Danacioglu Y.O et al. New J Urol 15, 176-181

4- Thefrequencyof theincidental prostatecancer ofthepatientsthatwere diagnosedasbladdercancerandunderwentradicalcystectomyand the oncological outcomes." Turan T., Danacioglu Y.Oet al. New J Urol 2018: 13, 16-21

5- Predictive parameters on the effect of ofloxacin treatment on the reduction ofPSA in patients with elevated PSA level. Teke Kerem., Danacioglu Y.O.,Polat,S. New J Urol 14, 166-175.

6- Auxiliary tests in the diagnosis of prostate cancer." Medeniyet Med J.Danacioglu Y.Oet al. 2018:33, 47-53

7- PenileMondor'sDisease: ASeriesofThreeCasesandLiterature Review. J Recons Urol. Seker K., Danacioglu Y.O. et al.10, 98-102

8- The Risk Factors of Unplanned Hospital Readmission FollowingPercutaneousNephrolithotomy." Danacıoğlu Y.O Ozlu D.N., Akkas F., Yenice M.G., Tasci A.İ.JAREM.2021: 11.1 69. Doi: 10.4274/jarem.galenos.2021.3915

9- PSA Değeri 4, 0-10, 0 ng/mL Arasında Olan Hastalarda İlk Biyopsi ÖncesiELISA Yöntemi ile Elde Edilen [-2] ProPSA ve Türevlerinin Prostat KanseriTanısındaki Etkinliği." Yenice M.G., Danacioglu Y.O., et al. J Recons Urol 2019: 9, 100-104.

10-SarcomatoidCarcinoma,aVariantHistologyoftheBladder:CaseSeriesand Literature Review." Danacıoğlu Y.Oet al. New J Urol. 14:182-188.

11-Current approaches in incontinence after prostatectomy surgery: A review of literature” J Recons Urol. Danacioglu Y.O et al. 2019, 9: 25-33 Doi: 10.5336/urology.2019-66618

12-The genetic causes of infertility in patients with oligozoospermia andazoospermia in Turkish population. Danacıoğlu, Y.O, Yenice M.G., Akkas F., Soytas M., Seyhan S., Tasci A.İ. New J Urol2021:16,159-164. Doi: 10.33719/yud.2021;16-2-834672

13-The approach of emergency physicians to patients with acute renal colic. Bozan O., Danacıoğlu Y.O, İslam M.M. New J Urol 2022, 17, 44-51. Doi:10.33719/yud.2022;17-1-1016256

14-At what stage are we in active surveillance for localized prostate cancer? Our clinical experience. Evren İ., Danacioglu Y.O., Eksi M., Ozlu D.N., Haciislamoglu A., Arikan Y., Ayten A., Polat H. New J Urol 2023, 18, 8-15. Doi:10.33719/yud.2023;18-1-1129666

15-Predicting Factors for Lymph Node Metastasis in Anterior Prostatic Fat Tissue Excised During Radical Prostatectomy. Akkas F., Danacioglu Y.O., Yenice M.G., Şeker G., Şahin S. Harran Med J., 2020, 17, 289-293. Doi: 10.35440/hutfd.728011

16-Risk Factors Affecting Success of Urethroplasty in Male Patients – Single Center Results. Danacioglu Y.O., Sungur U., Akkas F., Birinci M., Soytas M., Simsek A. Harran Med J., 2021, 18, 410-416. Doi: 10.35440/hutfd.1007386

17-Factors That Affecting Success and Re-admission in the Treatment of Proximal Ureteral Stones with Shock Wave Lithotripsy. Toprak T., Kutluhan M.A., Danacıoğlu Y.O., Arıkan Y., Arslan U., Topaktas R. The Medical Journal Of Haydarpaşa Numune Training and Research Hospital, 2022, 62, 42-7. Doi: 10.14744/hnhj.2020.03064

18-Disseminated bacillus calmette-guérin (bcg) ınfection caused by ınadvertent ıntravenous ınfusion of bcg for the treatment of bladder cancer: case. Danacıoğlu Y.O., Turan T., Yıldırım A., Caskurlu T. Turkiye Klinikleri Journal of Case Reports, 2017, 25. 128-131. Doi: 10.5336/caserep.2017-55785

19-Relationship between the prostate cancer screening attitudes, beliefs, and knowledge levels of men working in a healthcare institution. Ozdemir İ.N., Calıskan F., Danacıoğlu Y.O.New J Urol, 2023, 18: 173-182. Doi: 10.33719/yud.2023;18-2-1270777

20-Case Report: Successful resection of a bladder leiomyoma causing lower urinary tract symptoms. Danacıoğlu Y.O., Erol B., Zerk P.E., Gucluer B., Yildirim A., Caskurlu T. New J Urol, 2018, 13:49-52. Doi:

21- Synchronous Tumors: Renal Cell Carcinoma with Adenocarcinoma of the Ampulla of Vater; Case Report. Danacioglu Y.O., Keser F., Zerk P.E., Simsek B., Turan T. Medeniyet Med J, 2019,34: 208-212. Doi: 10.5222/MMJ.2019.08784

22-Practice patterns of turkish urologists regarding ıntravesical botulinum toxin-a ınjections for overactive bladder and neurogenic lower urinary tract dysfunction: a survey study. Coskun B., Bayrak O., Corabay S., Tahra A., Karakeci A., Colakoglu Y., Danacıoğlu Y.O., Onem K. J Recons Urol, 2023, 13:67-75. Doi: 10.5336/urology.2023-98660

23-İnterstisyel sistit (mesane ağrı sendromu) farmakoterapisi, sınıflandırılması, karakterizasyonu ve alt gruplandırılması. Danacıoğlu Y.O., Simsek A. Kontinans ve Nöroüroloji Bülteni, 2021, 8:29-36.

24-İki Olgu Eşliğinde Mesane Sarkomatoid Karsinomu. Danacıoğlu Y.O., Aydın Abdullah., Turan T., Güçlüer B., Yıldırım A. Ürolojik Onkoloji Bülteni, 2018, 2:75-80

25-Prostat Kanseri Tanısında ve Prognoz Öngörüsünde Kullanılan Biyobelirteçler. Danacıoğlu Y.O., Yucetas U. Ürolojik Onkoloji Bülteni, 2019, 3:15-23

Kitap Bölümleri

1- Üreteroskopi Sonrası Sepsis Ölüm Nedeni midir?DanaciogluY.O,Atis

R.G.Tıp Hukuku2017 Sayfa156-160

2- Testis Tümörlerine Yaklaşım.DanaciogluY.O,Yucetas. U.Ürolojide Temel Yaklaşım ve Yönetim2019 Bölüm49 Sayfa 533-544

3- Üriner Sistem Taş Hastalığında ESWL'nin Son Durumu.Danacioglu Y.O,AtisR.G. Güncel Üroloji-2. 2018 Sayfa713-721

4- Adolesen varikosel.PolatS.,DanaciogluY.O.Sağlık Bilimleride Multidisipliner Yaklaşım 2020 Sayfa275-293

5- URS-RIRC.DanaciogluY.O,AtisR.G.Ürolojide Sık Kullanılan Deney Hayvan Modelleri 2020 Sayfa267-273

6- Renal İnfarkt. Danacioglu Y.O., Şahin S. Ürolojik Aciller 2022 Sayfa 133-144

7- GOSSİPİBOMA: Mutlak Bir İnsan Hatası mıdır? Olgu Sunumu ve Literatür Değerlendirilmesi. Danacioglu Y.O., Arikan Y. Ürolojik Vakalar, Tedaviler ve Literatürde Yaklaşım 2019Sayfa 25-35

8- İntravezikal Farmakoterapi ve İntravezikal Elektrostimulasyon. Danacioglu Y.O, Polat S. Nöroüroloji 2024 Sayfa 61-73

9- Abiraterone Acetate Therapy for Metastatic Prostate Cancer. Polat H., Danacioglu Y.O. Current management of metastatic prostate cancer. 2024 Sayfa 89-96

Üroloji

Doç. Dr. Mithat EKŞİ Department of Urology, University of Health Science, Dr.Sadi Konuk Training and Research Hospital, İstanbul, Türkiye

MİTHAT EKŞİ, M.D

Language: Turkish, English

E.mail: mithat_eksi@hotmail.com

Department of Urology, University of Health Sciences, Bakırköy Dr.Sadi Konuk Training and Research Hospital, Türkiye

EDUCATION

2007‐2013: Cerrahpaşa Faculty of Medicine, Istanbul University Medical Student

2013‐2018: Bakırköy Dr.Sadi Konuk Training and Research Hospitall Urology Resident

CLINICAL INTEREST

Urooncology, Minimally Invasive Surgery, Transplantation

PROFESSIONAL MEMBERSHIPS

European Association of Urology Turkish Journal of Urology Society of Urological Surgery

Üroloji

Doç. Dr. Salih POLAT SAĞLIK BAKANLIĞI İZMİR BUCA EĞİTİM ARAŞTIRMA HASTANESİ

Üroloji

Dr. Öğr. Üyesi Büşra EMİR İZMİR KATİP ÇELEBİ ÜNİVERSİTESİ, TIP FAKÜLTESİ, TEMEL TIP BİLİMLERİ BÖLÜMÜ, BİYOİSTATİSTİK ANABİLİM DALI

Biyoistatistik

Dr. Serda GÜZEL İSTANBUL AREL ÜNİVERSİTESİ

Çeviri ve Yorum Çalışmaları, Dil Edinimi, Çocuğun Dil Edinimi, Dil Kullanım Bilimi, Söylem ve Bağlamsal Dilbilim, Sözlükbilim ve Anlambilim, Toplumsal Dilbilim, Uygulamalı Dilbilim ve Eğitim Dilbilimi , Metindilbilim, Edebiyat Sosyolojisi

Doç. Dr. Murat ŞAHAN İzmir Şehir Hastanesi

Üroloji

Dr. Öğr. Üyesi Samet ŞENEL Ankara City Hospital

Üroloji

Doç. Dr. Mustafa SOYTAŞ Bir kuruma bağlı değildir

Üroloji

Amaç ve Kapsam

The New Journal of Urology (New J Urol) is a scientific, peer-reviewed, open access publication and it aims to improve the standards in the field of urology including the education of academicians and the professionals.The New Journal of Urology (New J Urol) is a scientific, referred, open access publication of the Eurasian Urooncological Association. The society is a non-profit organization and it aims to increase the standards in the field of urology including education of the academicians, professionals and public. The society The New Journal of Urology also aims to create or make contributions for the development of technical, scientific and social facilities and it also cooperates with any and all related institutions, organizations, foundations and societies from the national and international area for this purpose.

The journal' s financial expenses are covered by the Eurasian Urooncological Association. The journal is published quarterly tri-annual– (three times a year)- in February, June and October, respectively and the language of the journal is Turkish and English.

The purpose of the New Journal of Urology The New Journal of Urology is to contribute to the literature by publishing urological manuscripts such as scientific articles, reviews, letters to the editor, case reports, reports of surgical techniques, surgical history, ethics, surgical education and articles of forensic medicine.

The target audience of the journal is urologists, specialist doctors and other professionals interested in the field of urology.

The New Journal of Urology has been indexed by TUBITAK ULAKBIM-TR DİZİN, DOAJ, Google Schoolar, Scilit, EBSCO, SOBIAD Citation Index, OAJI, İdeal Online, Turkish Citation Index, and TurkMedline (National Health Sciences-Periodicals Database).

The New Journal of Urology ceased printing in 2024 (ISSN: 1305-2489, eISSN: 2687-1955).

The New Journal of Urology is now only published online with the eISSN: 3023-6940.

The journal is integrated with ORCID and CrosReff DOI.

All published content is available for free at https://newjournalurology.com/archive.

All manuscripts submitted to the journal should be submitted via the online submission system, which is available at the https://dergipark.org.tr/en/journal/4362/submission/step/manuscript/new.

Instructions for authors, including technical information and required forms, can be found at https://dergipark.org.tr/en/pub/newurology/writing-rules.

Editorial and publication processes of the journal are shaped in accordance with the guidelines of the international organizations such as the International Council of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), the Committee on Publication Ethics (COPE). Our journal follows the principles of transparency and best practices for scholarly publishing as identified by the Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishing Association (OASPA), and the World Association of Medical Editors (WAME) (doi: 10.24318/cope.2019.1.12).

The statements and/or opinions indicated at the articles which are published at the journal reflect the views of the author, not the opinions of the editors, editorial board and / or the Publisher. Editors and publishers do not accept any responsibility for such materials.

No fee is required for submitting articles, evaluation, processing or publishing process from the authors.

Authors' credentials and e-mail addresses are in no way used for other purposes.

The journal will allow the authors to retain publishing rights without restrictions.

All published content in The New Journal of Urology are licensed under Creative Commons CC BY Attribution 4.0 International License. Authors consent to publication of their work by The New Journal of Urology under a Creative Commons CC BY Attribution 4.0 International License.

Editor-in-Chief

Ali İhsan Taşçı

Department of Urology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, Türkiye

E-mail: aliihsantasci@hotmail.com

ORCID ID: https://orcid.org/0000-0002-6943-6676

Editor

Yavuz Onur Danacıoğlu

Department of Urology, Dr. Sadi Konuk Training and Research Hospital, Istanbul, Türkiye

E-mail: dr_yonur@hotmail.com

ORCID ID: https://orcid.org/0000-0002-3170-062X

Deputy Editor-in-Chief

Mithat Ekşi

Department of Urology, Dr.Sadi Konuk Training and Research Hospital, Istanbul, Türkiye

E-mail: mithat_eksi@hotmail.com

ORCID ID: https://orcid.org/0000-0003-1490-3756

Publishing Services

Pera Publishing Services

Address: Ataköy 3-4-11 Kısım Mah. Dr Remzi Kazancıgil Cd. O-114 N:12 D:7 PC: 34158, Bakırköy, İstanbul / Türkiye

E-mail: info@perayayincilik.com

Yazım Kuralları

General Guidelines

Manuscripts can only be submitted through the journal’s online manuscript submission and evaluation system, available at https://dergipark.org.tr/en/journal/4362/submission/step/manuscript/new. Manuscripts submitted via any other medium will not be evaluated. Manuscripts submitted to the journal will first go through a technical evaluation process where the editorial office staff will ensure that the manuscript has been prepared and submitted in accordance with the journal’s guidelines. Submissions that do not conform to the journal’s guidelines will be returned to the submitting author with technical correction requests. The editor reserves the right to reject manuscripts that do not comply with the above-mentioned requirements. Editors have the right to make corrections without changing the main text. The ORCID (Open Researcher and Contributor ID) number of the authors should be provided while sending the manuscript. A free registration can be done at https://orcid.org.

For experimental, clinical, and drug studies mandated to be approved by an ethical committee for publication in The New Journal of Urology, the authors must furnish an ethical committee approval report in line with international agreements (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/).

In the case of experimental animal studies, adherence to animal rights guidelines ("Guide for the Care and Use of Laboratory Animals" https://www.ncbi.nlm.nih.gov/books/NBK54050) is mandatory, with requisite approval from the animal ethics committee.

The "Materials and Methods" section must specify the ethical committee's approval, including the approval number, and the provision of "informed consent" by patients.

Authors are obligated to disclose conflicts of interest and financial support related to their articles.

The rules for the title page, references, figures and tables are valid for all types of articles published in this journal.

Authors are required to submit the following:

• Cover Letter

• Copyrıght Agreement and Acknowledgement of Authorship Form

• Patient Consent Form

• ICMJE Disclosure of Interest

• Title Page

• Main text

• Figures

• Tables

PREPARATION OF THE MANUSCRIPT

Authors should adhere to the ICJME recommendations for “preparing a manuscript for submission to a medical journal”. https://www.icmje.org/recommendations/browse/manuscript-preparation/preparing-for-submission.html

The articles should be written in 12-point, Times New Roman, double-spaced with at least 2.5 cm margin on all edges of each page. The main text should not include any information about the authors' names or affiliations. This information should only be included on the title page, along with their ORCID IDs, the title, abstract, and keywords.

All acronyms and abbreviations used in the manuscript should be defined at first use, both in the abstract and in the main text. The abbreviation should be explained clearly in parentheses following the definition and custom abbreviations should not be used.

Statistical analysis is usually necessary to support results in original articles. Information on statistical analyses should be provided with a separate subheading under the Materials and Methods section and the statistical software that was used during the process must be specified.

Whenever a product, software, or software program is mentioned in the main text, product information (including state in the USA) must be given in parentheses, including the product name, product manufacturer, city of production, and country of the company.

All references, tables, and figures should be sequentially numbered and referred to in the main text. All pages of the manuscript should be numbered at the bottom center, except for the title page. Papers should include the necessary number of tables and figures to provide better understanding.

Authors are required to prepare manuscripts in accordance with the relevant guideline listed below:

• Randomized research studies and clinical trials: CONSORT guidelines (for protocols, please see the SPIRIT guidance)

• Observational original research studies: STROBE guidelines

• Studies on diagnostic accuracy: STARD guidelines

• Systematic reviews and meta-analysis: PRISMA guidelines (for protocols, please see the PRISMA-P guidelines)

• Experimental animal studies: ARRIVE guidelines and Guide for the Care and Use of Laboratory Animals, 8th edition

• Nonrandomized evaluations of behavioral and public health interventions: TREND guidelines

• Case report: the CARE case report guidelines

• Genetic association studies: STREGA

• Qualitative research: SRQR guidelines

Manuscript Types

Original Articles

For original research, systematic reviews, and meta-analyses, structured abstracts are required. The abstract should provide background information and state the study's purpose, procedures (including participant selection, settings, measurements, and analytical methods), main findings (including specific effect sizes and their statistical and clinical significance, if possible), and principal conclusions. Abstracts should highlight novel and significant findings, acknowledge important limitations, and avoid overinterpretation. Inclusion of the essential elements identified by the CONSORT group is essential for clinical trial abstracts.

Original Research Articles should include subheadings below;

• Title

• Abstract

• Keywords

• Introduction

• Material and Methods

• Results

• Discussion

• Conclusions

• Figures and Tables Legend

• References

Review Articles

Review articles should provide a comprehensive overview of the current state of knowledge on a topic in clinical practice, and should include discussions and evaluations of relevant research. The subheadings of the review articles can be planned by the authors. Review articles are scientific analyses of recent developments on a specific topic as reported in the literature. No new information is described, and no opinions or personal experiences are expressed.

• Title

• Abstract (unstructured)

• Keywords

• Main text

• Conclusion

• Figures and Tables Legend

• References

Case Reports

New, interesting and rare cases can be reported. They should be unique, describing a great diagnostic or therapeutic challenge and providing a learning point for the readers. Cases with clinical significance or implications will be given priority.

Case Reports should include subheadings below;

• Title

• Abstract (unstructured)

• Keywords

• Introduction

• Case Presentation

• Discussion and Conclusion

• Figures and Tables Legend

• References

Letters to the Editor

A "Letter to the Editor" is a type of manuscript that discusses important or overlooked aspects of a previously published article. This type of manuscript may also present articles on subjects within the scope of the journal that are of interest to readers, particularly educational cases. Readers can also use the "Letter to the Editor" format to share their comments on published manuscripts. The text of a "Letter to the Editor" should be unstructured and should not include an abstract, keywords, tables, figures, images, or other media.

Letters to Editor should include subheadings below;

• Title

• Keywords

• Main text

• Figures and Table Legend

• References

Article Structure

Title page

A separate title page should be submitted with all submissions.

The title page should include:

1- The full title of the manuscript as well as a short title (running head) of ≤50 characters,

2- Name(s), affiliations, highest academic degree(s), and ORCID IDs of the author(s),

3- Name, address, telephone (including the mobile phone number), and email address of the corresponding author,

4- If the author(s) is a member of the journal’s Editorial Board, this should be specified in the title page,

5- If the content of the paper has been presented before, and if the summary has been published, the time and place of the conference should be denoted on this page,

6- If any grants or other financial support has been given by any institutions or firms for the study, information must be provided by the authors,

7- Acknowledgment of the individuals who contributed to the preparation of the manuscript but who do not fulfill the authorship criteria should be included.

Abstract

Original articles should have a structured English (Objective, Methods, Results, Conclusion). Review articles and case reports should have an unstructured abstract. Articles and abstracts should be written in accordance with the word limits specified in the table. References, tables and citations should not be used in an abstract.

Keywords

Each submission must be accompanied by a minimum of three to a maximum of six keywords for subject indexing at the end of the abstract. The keywords should be listed in full without abbreviations. The keywords should be selected from the National Library of Medicine, Medical Subject Headings database (https://www.nlm.nih.gov/mesh/MBrowser.html).

Limitations for each manuscript type;

Type of Article	Abstract word limit	Word limit	References limit	Table limit	Figure limit
Original Article	250 (Structured)	3000	30	6	5
Review Article	250 (Unstructured)	4000	50	6	6
Case Reports	250 (Unstructured)	2000	10	1	3
Letter to the Editor	No abstract	1000	5	1	1

Figures and Tables

Figures, graphics, illustrations and photographs should be submitted as separate files (in JPEG or PNG format) through the submission system. The files should not be embedded in a word file of the main document. When there are figure subunits, the subunits should not be merged to form a single image. Each subunit should be submitted separately through the submission system.

Figures should be labeled with Arabic numbers. Thick and thin arrows, arrowheads, stars, asterisks, and similar marks may be used on the images to support figure legends. The minimum resolution of each submitted figure should be 300 DPI. Written informed consent for publication must be obtained for all images and must not allow patients to be identified. Figure legends should be listed at the end of the main document. Figures must be numbered consecutively in the order in which they are mentioned in the main text.

Tables should not embed in the main document. Tables should support and enhance the main text rather than repeat data presented in the main text. All tables should be numbered consecutively in the order they are used to within the main text. Table legends should be listed at the end of the main document.

Units of Measurement

Units of length, weight and volume should be reported in metric (meter, kilogram, liter) system and in decimal multiples. Temperatures should be expressed in degrees Celsius, and blood pressures in millimeters of mercury. Both local and International Unit Systems (International System of Units, SI) should be used as measurement units. Drug concentrations should alternatively be given in either SI units or mass units written in parentheses.

Abbreviations and Symbols

Use only standard abbreviations, non-standard abbreviations can be very confusing for the reader. The use of abbreviation(s) should be avoided in the title. If there is no standard unit of measurement, provide the long version of the abbreviation in parentheses when it is first used in the text.

Supplementary Materials

Supplementary materials, including audio files, videos, datasets, and additional documents (e.g., appendices, additional figures, tables), are intended to complement the main text of the manuscript. These supplementary materials should be submitted as a separate section after the references list. Concise descriptions of each supplementary material should be included to explain their relevance to the manuscript. Page numbers are not required for supplementary materials.

Identifying Products

When mentioning a drug, product, hardware, or software program in a manuscript, it is important to provide detailed information about the product in parentheses. This should include the name of the product, the producer of the product, and the city and country of the company.

Author Contributions

When submitting to The New Journal of Urology, corresponding authors must provide a signed and scanned authorship contribution form, which can be downloaded from https://dergipark.org.tr/en/pub/newurology/page/16601. This requirement is in place to ensure proper authorship attribution and prevent ghost or honorary authorship.

References

While citing publications, preference should be given to the latest, most up-to-date publications. Authors should avoid using references that are older than ten years. All the references should be written according to the Vancouver reference style. The references used in the article must be written in parenthesis, at the end of the sentences. References should be numbered in the order they appear in the text and listed in the same order in which they are cited in the text. Be consistent with your referencing style across the document.

References must contain surnames and initials of all authors, article title, name of the journal, the year and the first and last page numbers. If there are more than 6 authors, an abbreviation of “et al.” should be used for the authors out of the first three.

You must add the DOI (Digital object identifier) at end of each reference.

For Examples

Article in journal:

Tasci A, Tugcu V, Ozbay B, et al. Stone formation in prostatic urethra after potassium-titanyl-phosphate laser ablation of the prostate for benign prostatic hyperplasia. J Endourol.2009;23:1879-1881. https://doi.org/10.1089/end.2008.0596

For Books:

Günalp İ. Modern Üroloji. Ankara: Yargıçoğlu Matbaası, 1975.

Chapters in books: Anderson JL, Muhlestein JB. Extra corporeal ureteric stenting during laparoscopic pyeloplasty. Philadelphia: W.B. Saunders, 2003; p. 288-307.

For website;

Gaudin S. How moon landing changed technology history [serial online]. 2009 [cited 2014 June 15]. Available from: http://www.computerworlduk.com/in-depth/it-business/2387/how-moon-landing-changed-technology-history/

For conference proceeding;

Anderson JC. Current status of chorion villus biopsy. Paper presented at: APSB 1986. Proceedings of the 4th Congress of the Australian Perinatal Society, Mothers and Babies; 1986 Sep 8-10; Queensland, Australian. Berlin: Springer; 1986. p. 182-191.

For Thesis;

Ercan S. Venöz yetmezlikli hastalarda kalf kası egzersizlerinin venöz fonksiyona ve kas gücüne etkisi. Süleyman Demirel Üniversitesi Tıp Fakültesi Spor Hekimliği Anabilim Dalı Uzmanlık Tezi. Isparta: Süleyman Demirel Üniversitesi; 2016.

Manuscript Retraction

For any other reason authors may withdraw their manuscript from the journal with a written declaration.

Revisions

When submitting a revised version of a paper, the author must submit a detailed “Response to the reviewers” that states point by point how each issue raised by the reviewers has been covered and where it can be found (each reviewer’s comment, followed by the author’s reply and line numbers where the changes have been made) as well as an annotated copy of the main document. If the revised version of the manuscript is not submitted within the allocated time, the revision option may be canceled. If the submitting author(s) believe that additional time is required, they should request this extension before the initial period is over.

After Acceptance

Accepted manuscripts are copy-edited for grammar, punctuation, and format. A PDF proof of the accepted manuscript is sent to the corresponding author and their publication approval is requested. The journal owner and the editorial board are authorized to decide in which volume of the accepted article will be printed. Authors may publish their articles on their personal or corporate websites by linking them to the appropriate cite and library rules.

Requests for author change (name, author addition) will be evaluated if submitted to the Editorial Board (publisher/journal address) with a letter signed by all authors before the evaluation process is completed. No author changes will be made after the article is assigned to the issue and published.

Etik İlkeler ve Yayın Politikası

Ethical Principles and Publication Policy

Instructions for authors are shaped on the recommendations of International Committee of Medical Journal Editors (http://www.icmje.org/recommendations/).

The ethics of The New Journal of Urology have been established in accordance with the guidelines of Committee on Publication Ethics (COPE) (https://doi.org/10.24318/cope.2019.2.24).

The Editorial Board follows to the recommendations of International Committee of Medical Journal Editors (ICJME) for dealing with scientific misconduct, such as falsification of data, plagiarism, improprieties of authorship, violation of generally accepted research practices and redundant publication and duplicate publication.

Originality, high scientific quality and citation potential are the most important criteria for a manuscript to be accepted for publication. Manuscripts submitted for evaluation should not have been previously presented or already published in an electronic or printed medium. Manuscripts that have been presented in a meeting should be submitted with detailed information on the organization, including the name, date, and location of the organization.

An approval of research protocols by the Ethics Committee in accordance with international agreements World Medical Association Declaration of Helsinki ( https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/) is required for experimental, clinical, and drug studies and for some case reports.

If required, ethics committee reports or an equivalent official document will be requested from the authors.

If there is any concern or dispute at over the studies, we will follow the flowcharts of Committee on Publication Ethics (COPE) to solve them.. https://doi.org/10.24318/cope.2019.2.26

Disclosure of Conflicts of Interest

A conflict of interest may exist when an author (or the author's institution or employer) has financial or personal relationships or affiliations that could influence the author's decisions or work on the manuscript. Authors are required to identify all relevant financial interests and relationships or financial conflicts (e.g., employment/affiliation, grants or funding, consultancies, stock ownership or options, royalties, or patents filed, received, or pending), particularly those present at the time the research was conducted and through publication, as well as other financial interests that represent potential future financial gain. The disclosure of funding should be indicated in the Acknowledgments section within the manuscript.

The “Copyright Agreement and Acknowledgement of Authorship Form” should be completed by the corresponding author on behalf of each coauthor and should be submitted with the manuscript.

The Editorial Board of The New Journal of Urology will immediately reject a submitting manuscript which has a high similarity index to other papers in the Similarity Check. When malpractices are found in the submitted article to The New Journal of Urology, Editorial Board will follow the flowchart by the Committee on Publication Ethics (COPE) for settlement of any misconduct. The Editorial Board of The New Journal of Urology is always willing to publish corrections, clarifications, retractions when needed.

Responsibilities of Author

The Editorial Board of the journal handles all appeal and complaint cases within the scope of Committee on Publication Ethics guidelines (COPE). In such cases, authors should get in direct contact with the editorial office regarding their appeals and complaints. When needed, an ombudsperson may be assigned to resolve cases that cannot be resolved internally. The Editor-in-Chief is the final authority in the decision-making process for all appeals and complaints.

The New Journal of Urolgy requires each submission to be accompanied by Copyright Agreement and Acknowledgement of Authorship Form. When using previously published content, including figures, tables, or any other material in both print and electronic formats, authors must obtain permission from the copyright holder. Legal, financial and criminal liabilities in this regard belong to the author(s).

• For manuscripts concerning experimental research on humans, a statement should be included that shows that written informed consent of patients and volunteers was obtained following a detailed explanation of the procedures that they may undergo.

• For studies carried out on animals, the measures taken to prevent pain and suffering of the animals should be stated clearly.

• Information on patient consent, the name of the ethics committee, and the ethics committee approval number should also be stated in the Materials and Methods section of the manuscript.

• It is the authors’ responsibility to carefully protect the patients’ anonymity. For photographs that may reveal the identity of the patients, releases signed by the patient or their legal representative should be enclosed.

All submissions are screened by a similarity detection software (iThenticate) and the limitation without similarity is 20%.

Statements or opinions expressed in the manuscripts published in The New Journal of Urology reflect the views of the author(s) and not the opinions of the editors, the editorial board, or the publisher; the editors, the editorial board, and the publisher disclaim any responsibility or liability for such materials. The final responsibility in regard to the published content rests with the authors.

Open Access&Deposit Policy

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supporting a greater global exchange of knowledge.

Every paper published in The New Journal of Urology is freely available via the website https://newjournalurology.com/archive .

Open Access Policy is based on rules of Budapest Open Access Initiative (BOAI) http://www.budapestopenaccessinitiative.org/.

Deposit Policy

Deposit policy (Self-archiving policy) are as follows:

• Author can archive pre-print (i.e., pre-refereeing);

• Author can archive postprint (i.e., final draft after refereeing);

• and Author can archive publisher's version/PDF.

All published content in The New Journal of Urology are licensed under Creative Commons CC BY Attribution 4.0 International License.

Copright&Licensing

The New Journal of Urolgy requires each submission to be accompanied by a Copyrıght Agreement and Acknowledgement of Authorship Form. When using previously published content, including figures, tables, or any other material in both print and electronic formats, authors must obtain permission from the copyright holder. Legal, financial and criminal liabilities in this regard belong to the author(s).

The contents can be used as a reference in scientific publications and presentations.

The New Journal of Urology allows the author to retain copyright without restriction.

There is no charge for publishing, or no copyright fee is paid to the authors.

No fee is required for submitting articles, evaluation, processing or publishing process from the authors.

Lisencing

All published content in The New Journal of Urology are licensed under Creative Commons Attribution CC-BY 4.0 International License. Authors consent to publication of their work by The New Journal of Urology under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Under this licence, the third parties and authors are free to copy, distribute, transmit, adapt, and even make commercial use of the material, provided the article is properly cited.

Provided that the original author(s) and citation details are acknowledged, the authors grant any third party the right to use the article freely.
Authors grant this journal permission to publish the article and to identify itself as the original publisher.
The authors have confirmed their contribution to this work and have read and signed the conflict of interest declaration. Authors warrant that they have approved and are responsible for the article or any material contained therein.
The authors must ensure that the study under consideration is original and does not contain plagiarized content. The content in question must be original and not otherwise under copyright elsewhere (in whole or in part).
The authors warrant that the contribution or any material contained therein has not been published previously and will not be submitted for publication elsewhere.
The authors must avoid duplicate publication, which is reproducing verbatim content from their other publications.
The authors retain copyright without restriction.
All commercial rights associated with the contribution are retained by the contributors.
Nothing in this licence should be construed as impinging on the author's right to maintain the integrity and ownership of his or her work or as detracting from or restricting it.

If there is any concern or dispute at over the studies, we will follow the flowcharts of Committee on Publication Ethics (COPE) to solve them. https://doi.org/10.24318/cope.2019.2.26

Plagiarism

Definition

When an author tries to present the work of someone else as his or her own, it is called plagiarism. In addition, when an author uses a considerable portion of his or her own previously published work in a new one without properly citing the reference, it is called a duplicate publication; sometimes also referred to as self-plagiarism. This may range from publishing the same article in another journal to 'salami-slicing', which is data segmentation, to adding little new data to the previous article.

Policy

The New Journal of Urology journal uses the Crossref Similarity Check program for scanning plagiarism. The articles to be published are required to have less than 20% similarity. If suspected plagiarism is found in an article either before (by reviewers or editorial team) or after (by readers) publication, the journal will act according to COPE’s code of conduct and flowcharts.

Declaration of Generative AI in Scientific Writing

Nowadays, the use of artificial intelligence in the writing of original research articles is becoming widespread thanks to the developing technological conditions. The author is obliged to follow the ethical standards regarding the use of artificial intelligence in the writing of articles submitted to the New Journal of Urology. Where authors use generative artificial intelligence (AI) and AI-assisted technologies in the writing process, authors should only use these technologies to improve readability and language. This may constitute standard plagiarism as the use of AI does not meet the criteria for authorship.

Applying the technology should be done with human oversight and control, and authors should carefully review and edit the result, as AI can generate authoritative-sounding output that can be incorrect, incomplete or biased. AI and AI-assisted technologies should not be listed as an author or co-author, or be cited as an author. The editors and reviewers of the New Journal of Urology are careful to evaluate the text in terms of the use of artificial intelligence tools that can generate references.

Authors should disclose in their manuscript the use of AI and AI-assisted technologies in the writing process. A statement should appear in the published work. Please note that authors are ultimately responsible and accountable for the contents of the work.

Ücret Politikası

There is no charge for publishing, or no copyright fee is paid to the authors.
No fee is required for submitting articles, evaluation, processing or publishing process from the authors.

Kapak Resmi İndir

Sayı Dosyaları

Arşiv

Cilt: 20 Sayı: 2, 29.06.2025

Araştırma Makalesi

Sayfa : 64-70

Sayfa : 71-78

Sayfa : 79-88

Sayfa : 89-96

Sayfa : 97-103

Sayfa : 104-112

Olgu Sunumları

Sayfa : 113-116

Sayfa : 117-120

Sayı Editör Kurulu

Amaç ve Kapsam

Yazım Kuralları

General Guidelines

PREPARATION OF THE MANUSCRIPT

Etik İlkeler ve Yayın Politikası

Ücret Politikası